Recent Highlights
- Reset and restart the body clock of mice in a lab and ... Body clock mouse study suggests new drug potential Scientists have used experimental drugs being developed by Pfizer to reset and restart the body clock of mice in a lab and say their work may offer clues on a ... RecentNews.co.uk - 1 week, 4 days ago
- Told Trubion Pharmaceuticals it is dropping one rheumatoid arthritis drug from their ... Pfizer pulls one RA drug, keeps another in Trubion pact Pfizer has told Trubion Pharmaceuticals it is dropping one rheumatoid arthritis drug from their alliance but will keep developing a next-generation therapy for the disease. PharmaTimes - 2 months, 3 weeks ago
- Announced that Pfizer will join the SGC-led public-private collaboration to generate small ... Pfizer Joins Open-Access Medicinal Chemistry Public-Private Collaboration The Structural Genomics Consortium (SGC) and Pfizer have announced that Pfizer will join the SGC-led public-private collaboration to generate small molecule inhibitors - "chemical probes" - for proteins involved in ... Medical News Today - 2 months, 3 weeks ago
Latest Articles
1 day, 18 hours ago
Forbes: Most Profitable Hospitals Have 25% Operating Margin
A survey of hospital finances by Forbes found that "some American hospitals make 25 cents or more for every $1 in patient revenue they take in," Forbes reports. The list, ...
Medical News Today - noon Thursday 2nd September 2010 BST
View Article
Related Articles
Email to Friend
2 days, 18 hours ago
More Health Overhaul Policies Settle In
The tangible effects of some early-arriving health overhaul policies are beginning to surface. The Wall Street Journal: "Almost 2,000 employers and unions will be eligible to submit retirees' medical bills ...
Medical News Today - noon Wednesday 1st September 2010 BST
View Article
Related Articles
Email to Friend
3 days, 14 hours ago
Drug cuts stroke risk by half vs aspirin: study
An experimental drug from Bristol-Myers Squibb and Pfizer reduces the risk of stroke by more than half compared with aspirin, with no significant rise in major bleeding, researchers said on ...
RecentNews.co.uk - 4:45 p.m. Tuesday 31st August 2010 BST
View Article
Related Articles
Email to Friend
5 days, 22 hours ago
Amneal Announces FDA Approval For Spironolactone HCl Tablets
Amneal Pharmaceuticals, LLC is pleased to announce that it has received U.S. FDA approval to manufacture Spironolactone HCl tablets in 25 mg, 50 mg and 100 mg strengths effective July ...
Medical News Today - 8 a.m. Sunday 29th August 2010 BST
View Article
Related Articles
Email to Friend
1 week ago
Bristol-Myers Squibb And Pfizer Inc Evaluate Unmet Need In Patients With Atrial Fibrillation
Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer (NYSE: PFE) report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, ...
Medical News Today - 9 a.m. Friday 27th August 2010 BST
View Article
Related Articles
Email to Friend
1 week, 2 days ago
WHO Grants Prequalification Status To Pneumococcal Vaccine, Paving Way For U.N. Procurement
The WHO "has granted prequalification status to Pfizer Inc.'s children's pneumococcal vaccine, Prevenar 13, paving the way for United Nations agencies and governments to start ordering the product," the Associated ...
Medical News Today - 2 p.m. Wednesday 25th August 2010 BST
View Article
Related Articles
Email to Friend
1 week, 3 days ago
Stutent Did Not Improve Overall Survival In Patients With Previously Treated Advanced Non-small Cell Lung Cancer
The SUN 1087 trial of Stutent (sunitinib malate) combined with erlotinib versus just elrotinib did not improve overall survival in patients with previously treated NSCLC (non-small cell lung cancer), Pfizer ...
Medical News Today - 11 p.m. Tuesday 24th August 2010 BST
View Article
Related Articles
Email to Friend
World Health Organization Grants Prequalification To Prevenar 13, Pfizer's 13-Valent Pneumococcal Conjugate Vaccine For Infants And Young Children
The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of ...
Medical News Today - 9 a.m. Tuesday 24th August 2010 BST
View Article
Related Articles
Email to Friend
Topline Results From Phase 3 Trial Of Sunitinib With Erlotinib In Advanced Non-Small Cell Lung Cancer (NSCLC)
Pfizer Inc. (NYSE :PFE) announced that the SUN 1087 trial of sunitinib in combination with erlotinib versus erlotinib demonstrated a statistically significant improvement in Progression-Free but not in Overall Survival ...
Medical News Today - 9 a.m. Tuesday 24th August 2010 BST
View Article
Related Articles
Email to Friend
1 week, 4 days ago
Body clock mouse study suggests new drug potential
Scientists have used experimental drugs being developed by Pfizer to reset and restart the body clock of mice in a lab and say their work may offer clues on a ...
RecentNews.co.uk - 6:15 p.m. Monday 23rd August 2010 BST
View Article
Related Articles
Email to Friend
